LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.41 | 84.90 | 1431 | 8766 | 0.1632 | 0.5253 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.11 | 84.90 | 157 | 8988 | 0.0175 | 0.0957 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.11 | 84.90 | 1444 | 8988 | 0.1607 | 0.5239 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.11 | 84.90 | 92 | 8988 | 0.0102 | 0.0120 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.11 | 84.90 | 1461 | 8988 | 0.1626 | 0.5266 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.81 | 84.90 | 163 | 9132 | 0.0178 | 0.1015 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.81 | 84.90 | 1452 | 9132 | 0.1590 | 0.5230 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.81 | 84.90 | 109 | 9132 | 0.0119 | 0.0377 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.81 | 84.90 | 1512 | 9132 | 0.1656 | 0.5322 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.52 | 84.90 | 178 | 9214 | 0.0193 | 0.1157 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.52 | 84.90 | 1473 | 9214 | 0.1599 | 0.5250 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.52 | 84.90 | 108 | 9214 | 0.0117 | 0.0362 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.52 | 84.90 | 1546 | 9214 | 0.1678 | 0.5360 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.22 | 84.90 | 162 | 9343 | 0.0173 | 0.1000 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.22 | 84.90 | 1487 | 9343 | 0.1592 | 0.5252 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.22 | 84.90 | 110 | 9343 | 0.0118 | 0.0389 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.22 | 84.90 | 1568 | 9343 | 0.1678 | 0.5372 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.93 | 84.90 | 145 | 8970 | 0.0162 | 0.0829 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.93 | 84.90 | 1515 | 8970 | 0.1689 | 0.5351 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.93 | 84.90 | 100 | 8970 | 0.0111 | 0.0247 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 75.93 | 84.90 | 1568 | 8970 | 0.1748 | 0.5430 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 77.64 | 84.90 | 153 | 9245 | 0.0165 | 0.0909 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 77.64 | 84.90 | 1547 | 9245 | 0.1673 | 0.5356 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 77.64 | 84.90 | 112 | 9245 | 0.0121 | 0.0418 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 77.64 | 84.90 | 1598 | 9245 | 0.1728 | 0.5430 | MN20160318_Q02 | E18 |